Enhancer of zeste homolog 2 (EZH2) inhibitors

Leukemia & Lymphoma
Nitya GulatiLisa Giulino-Roth

Abstract

Dysregulation of the histone methyltransferase EZH2 plays a critical role in the development of a variety of malignancies including B-cell lymphomas. As a result, a series of small molecule inhibitors of EZH2 have been developed and studied in the pre-clinical setting. Three EZH2 inhibitors: tazemetostat (EPZ-6438), GSK2816126 and CPI-1205 have moved into phase I/phase II clinical trials in patients with non-Hodgkin lymphoma and genetically defined solid tumors. Early data from the tazemetostat trials indicate an acceptable safety profile and early signs of activity in diffuse large B-cell lymphoma and follicular lymphoma, including patients with EZH2 wild-type and mutant tumors. In this review, we present the rationale, key pre-clinical and early clinical findings of small molecule EZH2 inhibitors for use in lymphoma as well as future challenges and potential opportunities for combination therapies.

References

Dec 22, 1999·The Journal of Immunology : Official Journal of the American Association of Immunologists·F M RaaphorstC J Meijer
Jan 19, 2000·Nature·B D Strahl, C D Allis
Dec 24, 2002·Nature Immunology·I-Hsin SuAlexander Tarakhovsky
Dec 22, 2007·Nature Reviews. Immunology·Ulf Klein, Riccardo Dalla-Favera
Aug 30, 2008·Mutation Research·Jeffrey A Simon, Carol A Lange
Jun 11, 2009·Molecular Cancer Therapeutics·Tina Branscombe MirandaPeter A Jones
Nov 17, 2010·Proceedings of the National Academy of Sciences of the United States of America·Christopher J SneeringerRobert A Copeland
Jan 21, 2011·Nature·Raphaël Margueron, Danny Reinberg
Mar 4, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Andrew Chase, Nicholas C P Cross
Mar 10, 2011·Nature Medicine·Manuel Rodríguez-Paredes, Manel Esteller
Jul 29, 2011·Nature·Ryan D MorinMarco A Marra
Jan 10, 2012·Annual Review of Immunology·Gabriel D Victora, Michel C Nussenzweig
Jan 13, 2012·Nature Medicine·Panagiotis NtziachristosIannis Aifantis
Apr 14, 2012·Nature Reviews. Drug Discovery·Cheryl H ArrowsmithMatthieu Schapira
May 17, 2012·Cancer Discovery·Relja Popovic, Jonathan D Licht
Jul 10, 2012·Cell·Mark A Dawson, Tony Kouzarides
Aug 18, 2012·Nature Reviews. Cancer·Alan H ShihRoss L Levine
Oct 2, 2012·Nature Chemical Biology·Sarah K KnutsonKevin W Kuntz
Dec 14, 2012·Proceedings of the National Academy of Sciences of the United States of America·Wei QiEn Li
Apr 27, 2013·Proceedings of the National Academy of Sciences of the United States of America·Sarah K KnutsonHeike Keilhack
Aug 27, 2013·Nature Chemical Biology·Woojin KimStuart H Orkin
Nov 10, 2013·The Journal of Clinical Investigation·Marieta CaganovaStefano Casola
Apr 4, 2014·Genes & Development·Christopher M Weber, Steven Henikoff
Apr 5, 2014·Trends in Molecular Medicine·Katerina Hatzi, Ari Melnick
Dec 13, 2012·ACS Medicinal Chemistry Letters·Sharad K VermaWilliam H Miller
May 26, 2015·ACS Medicinal Chemistry Letters·John E CampbellRobert A Copeland
Jun 2, 2015·Experimental Hematology·Bowen XuGang Greg Wang
Jun 29, 2015·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Feng SunEli Chan
Jul 21, 2015·Bioorganic & Medicinal Chemistry Letters·Victor S GehlingBrian K Albrecht

❮ Previous
Next ❯

Citations

Feb 5, 2019·Current Oncology Reports·Sofia GentaAnastasios Stathis
May 28, 2019·Genes & Development·Jia-Ray YuDanny Reinberg
Jan 23, 2020·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Clement Chung
Feb 12, 2020·Biological Chemistry·Stephen L NuttRhys S Allan
May 29, 2020·Science Translational Medicine·Lin ZhangDihua Yu
Aug 26, 2020·Journal of Cellular Physiology·Chunsik Lee, Jong Kyong Kim
Mar 23, 2019·Epigenetics & Chromatin·Amelie AlfertKornelius Kerl
May 17, 2019·JCI Insight·Christine R KeenanRhys S Allan
Apr 16, 2019·Frontiers in Oncology·Mei HanWei Cui
May 26, 2018·Current Treatment Options in Oncology·Melody R Becnel, Loretta J Nastoupil
Aug 6, 2019·Frontiers in Cell and Developmental Biology·Jane BuglerDavid Vetrie
Apr 2, 2020·Blood Advances·Yana PikmanKimberly Stegmaier
Jun 21, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Mélanie LambertMarie-Hélène David-Cordonnier
Dec 4, 2019·Clinical Epigenetics·A GanesanMaría Berdasco
Nov 5, 2019·Frontiers in Genetics·Marcelo L RibeiroGaël Roué
May 27, 2020·Genetics and Molecular Biology·Jae Eun LeeJung Hwa Kim
Mar 14, 2020·Drugs·Sheridan M Hoy
Nov 17, 2020·Frontiers in Oncology·Pedro Luiz Porfirio XavierHeidge Fukumasu
Feb 6, 2020·Cold Spring Harbor Perspectives in Medicine·Cihangir DuyAri Melnick
Dec 3, 2020·Expert Review of Hematology·Wenyujing Zhou, Weihong Chen
Oct 21, 2020·European Journal of Medicinal Chemistry·Amr K A BassGamal El-Din A Abuo-Rahma
Feb 3, 2021·Journal of Medicinal Chemistry·Pei-Pei KungLuke Zehnder
Jan 23, 2021·Journal of Biochemistry·Shunsuke Hanaki, Midori Shimada
Dec 31, 2020·International Journal of Molecular Sciences·Satoshi Kaito, Atsushi Iwama
Feb 9, 2021·The American Journal of Pathology·Talha AnwarCelina G Kleer
Jan 10, 2020·Experimental and Molecular Pathology·Ellen Cristina Rivas LeonelSebastião Roberto Taboga
Mar 6, 2021·Molecular Therapy. Nucleic Acids·Xi YangYonghong Li
Mar 9, 2021·Frontiers in Physiology·Tingting LiShougang Zhuang
Apr 28, 2021·European Journal of Medicinal Chemistry·Xiaoxia LiangBo Jing
Jun 10, 2021·European Journal of Medicinal Chemistry·Ying-Chao DuanYuan-Yuan Guan

❮ Previous
Next ❯

Related Concepts

Related Feeds

CNS Lymphoma

In CNS lymphoma, cancerous cells from lymph tissues or other parts of the body form tumors in the brain and/or spinal cord. Here is the latest research on this rare non-Hodgkin lymphoma.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.